NHS National Framework for Sacubitril/Valsartan
NHS England
- Value
- £15,120,000
- Published
- 10 Nov 2026
- Deadline
- Not stated
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- UKC, United Kingdom
- Notice reference
- 106850-2026
Requirements summary
NHS England is planning an open-procedure framework agreement for sacubitril/valsartan, a pharmaceutical product, under reference CM/TNS/26/5771. The planned contract runs from 1 February 2028 to 31 January 2029, with a renewal option to 31 January 2031, and an estimated value of GBP 15,120,000 gross (GBP 12,600,000 net). Suppliers planning to introduce the molecule, or with questions about the upcoming procurement, are invited to contact the MPSC New Market Developments Team.
Key requirements
- Framework agreement for sacubitril/valsartan supply to NHS England
- Planned contract period from 1 February 2028 to 31 January 2029, with renewal to 31 January 2031
- Delivery addresses across seven English regions (UKC, UKD, UKF, UKG, UKH, UKJ, UKK)
- Estimated value of GBP 15,120,000 gross (GBP 12,600,000 net)
- Open procedure under the Procurement Act 2023, with SME suitability indicated
- Suppliers planning to introduce the molecule should contact the MPSC New Market Developments Team before the planned tender, with the future notice expected by 26 May 2027